Drugs / non-pegylated interferon
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02097849 Comparator | Feb 2015 → May 2016 | relapsing-remitting multiple sclerosis | Biogen | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | non-pegylated interferon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02097849 ↗ |